MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 52 filers reported holding MARKER THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22 | -99.9% | 84,068 | -16.0% | 0.00% | -50.0% |
| Q3 2022 | $37,000 | +12.1% | 100,068 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $33,000 | -17.5% | 100,068 | +11.1% | 0.00% | 0.0% |
| Q1 2022 | $40,000 | -32.2% | 90,068 | +44.0% | 0.00% | -33.3% |
| Q4 2021 | $59,000 | -50.0% | 62,568 | -10.7% | 0.00% | -50.0% |
| Q3 2021 | $118,000 | -39.5% | 70,068 | 0.0% | 0.01% | -33.3% |
| Q2 2021 | $195,000 | +24.2% | 70,068 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $157,000 | +53.9% | 70,068 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $102,000 | -29.2% | 70,068 | -27.1% | 0.01% | -35.7% |
| Q3 2020 | $144,000 | -36.8% | 96,165 | -12.7% | 0.01% | -36.4% |
| Q2 2020 | $228,000 | +71.4% | 110,174 | +57.2% | 0.02% | +37.5% |
| Q1 2020 | $133,000 | -28.9% | 70,068 | +7.7% | 0.02% | -5.9% |
| Q4 2019 | $187,000 | -35.3% | 65,068 | +15.0% | 0.02% | -39.3% |
| Q3 2019 | $289,000 | +77.3% | 56,568 | +175.7% | 0.03% | +75.0% |
| Q2 2019 | $163,000 | – | 20,520 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |